Bought because of the high gross margin of around 98.56 % and an operating margin of 24.75 %.

The (ROIC) of 13.2 % is above the industry average.

In the past it was a good idea to buy below the 200 day line.

I think the recent sell-off was exaggerated in the general market weakness.

$NBIX (+0,48 %)
$REGN (+0,69 %) Is there anyone here who is invested in Neurocrine or Regeneron?

The shares seem to be attractively priced at the moment and the companies appear to be financially sound. However, I'm not that familiar with the sector yet.

I would therefore be grateful for any opinions.